Literature DB >> 6810490

Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathy.

P Sié, E Letrenne, C Caranobe, M Genestal, B Cathala, B Boneu.   

Abstract

In order to detect impaired synthesis of blood coagulation factors associated to consumption coagulopathy, a simultaneous evaluation of factor II-related antigen (II rAg) and of antithrombin III (AT III) was carried out in 16 patients affected with severe defibrination. An in vitro preliminary study on plasma and serum demonstrated that the levels of II rAg and of AT III, assessed by the Laurell technique with Behring antisera, were not reduced by the coagulation process. The patients were, a posteriori, classified into two groups according to the absence (group A) or the presence (group B) of factors predisposing to liver failure such as metastasis, cirrhosis, and prolonged shock. II rAg and AT III levels are significantly correlated; they are in the normal range in group A but reduced in group B. Thus II rAg or AT III level determinations are useful markers in the detection of liver failure associated to the consumption phenomenon. These results also suggest that part of the decreased AT III levels reported in severe cases of disseminated intravascular coagulation may be the consequence of an associated liver failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6810490

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31

Review 2.  A summary of the Japan septic disseminated intravascular coagulation study.

Authors:  Mineji Hayakawa; Kota Ono
Journal:  Acute Med Surg       Date:  2018-01-10

3.  Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.

Authors:  Toshiaki Iba; Marcello Di Nisio; Jecko Thachil; Hideo Wada; Hidesaku Asakura; Koichi Sato; Naoya Kitamura; Daizoh Saitoh
Journal:  Crit Care       Date:  2016-09-14       Impact factor: 9.097

Review 4.  Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments.

Authors:  Mineji Hayakawa
Journal:  Open Access Emerg Med       Date:  2017-12-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.